Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors (Q48267756)

10 February 2018

title

Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors (English)

1 reference

10 February 2018

author name string

Saleh M

1 reference

10 February 2018

Wiegmans A

1 reference

10 February 2018

Malone Q

1 reference

10 February 2018

Stylli SS

1 reference

10 February 2018

Kaye AH

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

10 February 2018

Journal of the National Cancer Institute

published in

1 reference

10 February 2018

volume

1 reference

10 February 2018

issue

1 reference

10 February 2018

page(s)

438-445

1 reference

10 February 2018

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Gene delivery systems in surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

B-cell stimulatory factor-1/interleukin 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

The eosinophil-mediated antitumor activity of interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Gene therapy of metastatic cancer by in vivo retroviral gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

The paracrine role of tumour-derived mIL-4 on tumour-associated endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Human interleukin-4: An immunomodulator with potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Retroviral gene transfer using safe and efficient packaging cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

A retroviral vector that allows efficient co-expression of two genes and the versatility of alternate selection markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Transformation of rat cells by DNA of human adenovirus 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.5.438

21 January 2018

Identifiers

DOI

10.1093/JNCI/91.5.438

1 reference

10 February 2018

1 reference

10 February 2018